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http://dx.doi.org/10.1016/j.stemcr.2016.03.005SUMMARYNumerous developmentally regulated genes inmouse embryonic stem cells (ESCs) aremarked by both active (H3K4me3)- and polycomb
group (PcG)-mediated repressive (H3K27me3) histone modifications. This bivalent state is thought to be important for transcriptional
poising, but themechanisms that regulate bivalent genes and the bivalent state remain incompletely understood. Examining the contri-
bution of microRNAs (miRNAs) to the regulation of bivalent genes, we found that themiRNA biogenesis enzyme DICERwas required for
the binding of the PRC2 core components EZH2 and SUZ12, and for the presence of the PRC2-mediated histonemodificationH3K27me3
at many bivalent genes. Genes that lost bivalency were preferentially upregulated at themRNA and protein levels. Finally, reconstituting
Dicer-deficient ESCswith ESCmiRNAs restored bivalent gene repression and PRC2binding at formerly bivalent genes. Therefore,miRNAs
regulate bivalent genes and the bivalent state itself.INTRODUCTION
MicroRNAs (miRNAs) are small, non-coding RNAs that
negatively regulate the stability and translation of pro-
tein-coding transcripts through partial complementarity
with their 30 UTRs (Jaskiewicz and Filipowicz, 2008). There
have been reports that miRNAs affect histone modifica-
tions or DNA methylation in mammalian cells (Kanello-
poulou et al., 2005; Sinkkonen et al., 2008; Benetti et al.,
2008; Nesterova et al., 2008; Han et al., 2007), although
the mechanisms are often indirect. For example, miRNAs
post-transcriptionally control negative regulators of DNA
methyltransferases in mouse ESCs (Sinkkonen et al.,
2008; Benetti et al., 2008; Nesterova et al., 2008).
In mouse ESCs a set of developmental regulator genes is
characterized by the simultaneous presence of activating
and repressive histone modifications (Azuara et al., 2006;
Bernstein et al., 2006). This bivalent state is resolved during
ESC differentiation (Mikkelsen et al., 2007), suggesting that
bivalency keeps genes in a poised state to enable rapid acti-
vation or stable silencing upon differentiation (Pietersen
and van Lohuizen, 2008; Voigt et al., 2013). Bivalent genes
are prematurely expressed in ESCs that lack the PRC2 com-Stem Cell Reports j Vol. 6 j 635–642 j
This is an open access article under the Cponents EED (Azuara et al., 2006; Boyer et al., 2006) or
SUZ12 (Pasini et al., 2004). PRC2-deficient ESCs remain
viable and can self-renew (Pasini et al., 2007; Chamberlain
et al., 2008; Shen et al., 2008) but show reduced develop-
mental potential (Pasini et al., 2007; Chamberlain et al.,
2008; Shen et al., 2008), and PRC2 mutations are lethal
during post-implantation in vivo (Faust et al., 1995; O’Car-
roll et al., 2001; Pasini et al., 2004). Hence, polycomb
group (PcG) repression of bivalent genes may safeguard
the pluripotent state and the ability of ESCs to differentiate.
miRNAs affect key features of ESCs, including their
characteristic cell-cycle behavior (Wang et al., 2008).
miRNAs are critical for ESC pluripotency and differentia-
tion (Miyoshi et al., 2011; Anokye-Danko et al., 2011),
and somatic miRNAs facilitate differentiation by terminat-
ing the expression of pluripotency factors such as Nanog
(Melton et al., 2010). Although much is known about
ESC miRNAs, their impact on the regulation of bivalent
genes has not been systematically investigated. To address
this point we have analyzed the distribution of PRC2
core components and the regulation of bivalent genes in
ESCs deficient in the RNase III enzyme DICER, which is
required for the biogenesis of most miRNAs (JaskiewiczMay 10, 2016 j ª 2016 International Society for Stem Cell Research 635
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. DICER Maintains the Associa-
tion of the Core PRC2 Component EZH2
with Many Bivalent Genes in ESCs
(A) EZH2 occupancy at transcriptional start
sites of bivalent genes and numbers of EZH2-
peaked bivalent genes that were retained
(gray) or lost (orange) in Dicer-deficient
ESCs. See Figure 4A for a complementary
analysis of SUZ12 binding.
(B) ChIP-seq track of the Pax6 locus with
highlighted EZH2 peak.
(C) ChIP-PCR of EZH2 (top), H3K27me3
(middle), and H3K4me3 (bottom) at selected
genomic sites. Mean ± SD of three indepen-
dent experiments. *p < 0.05 between control
and Dicer-deficient cells. EZH2 enrichment is
relative to input; H3K27me3 and H3K4me3
are relative to H3.
(D) Time-course analysis of Dicer deletion
and loss of the miRNAs miR-291a-3p and
miR-92 in Dicerlox/lox ERt2Cre ESCs treated
with carrier (EtOH) or 4-OHT. Expression of
Dicer mRNA is shown relative to Hprt;
expression of miRNAs is shown relative to
snoRNA-135. Mean ± SD of three indepen-
dent experiments. *p < 0.05 (t test) between
day 0 and the time points indicated.
(E) EZH2 occupancy of formerly bivalent
gene promoters within 8 days of ERt2Cre
activation. Mean ± SD of three independent
experiments. *p < 0.05 (t test) between
untreated cells (day 0) and cells treated with
either EtOH or 4-OHT.and Filipowicz, 2008).Wefind thatmiRNAs are required for
the binding of EZH2 and SUZ12 at many bivalent pro-
moters, and therefore for the maintenance of the bivalent
state. These data define an unexpected role for miRNAs in
maintaining the bivalent state of developmental regulator
genes in mouse ESCs.RESULTS AND DISCUSSION
Previously characterized Dicer-deficient ESCs (Nesterova
et al., 2008) were adapted to growth in feeder-free culture
with inhibitors of MEK and GSK3b (see Experimental
Procedures). We mapped the distribution of EZH2 by
chromatin immunoprecipitation and high-throughput
sequencing (ChIP-seq). Control ESCs retained EZH2 pro-
moter binding at 2,110 bivalent genes (Ku et al., 2008) in
control ESCs under 2i/LIF culture conditions. Loss of
DICER resulted in reduced EZH2 occupancy of bivalent
gene promoters (Figure 1A, left). The number of bivalent
promoters was reduced to 1,033, reflecting the loss of
EZH2 binding to 1,077 (or 51%) of formerly bivalent genes636 Stem Cell Reports j Vol. 6 j 635–642 j May 10, 2016(Figure 1A, right) as illustrated for the Pax6 promoter
(Figure 1B).
Loss of EZH2 was confirmed by ChIP-PCR (Figure 1C,
top). At the sites we tested, the H3K27me3 chromatin
mark deposited by PRC2 was reduced (Figure 1C, middle).
As expected (Marks et al., 2012), the promoter mark
H3K4me3 was unaffected (Figure 1C, bottom). To explore
the kinetics of EZH2 loss from bivalent promoters, we
induced the deletion of Dicer by treatment of ERt2Cre
Dicerlox/lox ESCs with 4-hydroxytamoxifen (4-OHT). Dicer
mRNA expression declinedwithin 4 days of ERt2Cre induc-
tion, followed by the reduced expression of the miRNAs
miR-291a-3p and miR-92 (Figure 1D). EZH2 occupancy of
formerly bivalent promoters was reduced within 8 days
(Figure 1E), indicating that EZH2 binding closely follows
the reduced expression of miRNAs.
qRT-PCR showed that the expression of the PRC2
core components Ezh2, Suz12, and Eed was not redu-
ced uponDicer deletion (Figure 2A). Similarly immunoblot-
ting showed no reduction of EZH2, SUZ12, or JARID2
proteins or global H3K4me3 or H3K27me3 (Figure 2B).
Cellular fractionation experiments confirmed that total
*
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Figure 2. Dicer Deletion Does Not
Diminish the Expression of PcG Proteins,
the Association of EZH2 with Chromatin,
or Global DNA Methylation in ESCs
(A) qRT-PCR of the PRC2 components Ezh2,
Suz1, Eed, and Jarid2. Mean ± SD of three
independent experiments. *p < 0.05 (t test)
between control and Dicer-deficient cells.
(B) Immunoblots of the PRC2 components
EZH2, SUZ12, EED, and JARID2 and the his-
tone modifications H3K4me3 and H3K27me3
in control and Dicer-deficient ESCs. Left:
representative blots. Right: densitometry
readings of three independent experiments;
*p < 0.05. DICER protein is a control.
(C) Immunoblots of cytoplasmic (Cy), nuclear
soluble (Nu) and chromatin-associated (Ch)
fractions of control and Dicer-deficient ESCs.
Histone H3 identifies the chromatin fraction.
(D) ERT2Cre Dicerlox/lox ESCs were treated with
either 4-OHT or carrier control (EtOH) and the
fraction of methylated cytosine residues was
followed by high-performance liquid chro-
matography.
See also Figure S1.and chromatin-associated EZH2 protein remained un-
changed (Figure 2C), suggesting selectively reduced bind-
ing of EZH2 at the promoters of bivalent genes.
Exclusion of PcG from CpG-methylated regions may
focus PcG binding to sites of lowCpGmethylation, namely
CpG islands andCG-rich promoter regions, to facilitate the
formation of bivalent domains (Ku et al., 2008; Lynch et al.,
2012; Brinkman et al., 2012). Global DNA methylation
levels are reduced inmostDicer-deficient ESC lines (Sinkko-
nen et al., 2008; Benetti et al., 2008; Nesterova et al., 2008;
Ip et al., 2012) and DNA hypomethylation is linked to
PcG redistribution in DNA methyltransferase (Dnmt)-defi-
cient ESCs (Lynch et al., 2012; Brinkman et al., 2012;
Cooper et al., 2014). PRDM14 controls Dnmt3b expression
(Ma et al., 2011) and is upregulated under 2i conditions
(Ying et al., 2008), but Prdm14 mRNA did not further in-
crease in Dicer-deficient ESCs (log2 fold change 0.36,
adjusted p = 0.446). Nevertheless, there were differences
in Dnmt mRNA (Figure S1A) and DNMT protein (Fig-
ure S1B) expression between control and Dicer-deficient
ESC under 2i/LIF culture conditions (Figure S1A).We there-fore used high-performance liquid chromatography to
directly monitor the fraction of methylated cytosine resi-
dues in response to Dicer deletion. Treatment of ERt2Cre
Dicerlox/lox ESCs with 4-OHT did not affect the fraction of
methylated cytosines (Figure 2D) even though miRNAs
were efficiently depleted (Figure 1D) and EZH2 occupancy
was reduced at bivalent promoters (Figures 1A–1D). Hence,
the observed loss of bivalency was not due to globally
reduced DNA methylation. Consistent with these data,
ChIP-seq and ChIP-PCR analysis showed no substantial
redistribution of EZH2 to repeat regions or to other
genomic regions that had been reported to gain PRC2 bind-
ing in DNMT-deficient ESCs (Figures S1C–S1F).
We explored other potentialmechanisms for the observed
redistribution of PcG proteins in Dicer-deficient ESCs. First,
although ERK2 is required for PRC2 occupancy and poised
RNA polymerase at developmental genes (Tee et al., 2014),
immunoblotting showed no significant differences in ERK1
and -2 protein expression between control and Dicer-defi-
cient ESCs (Figure S1G). Second, NUP153 promotes PcG
binding todevelopmentally regulated genes in ESCs (JacintoStem Cell Reports j Vol. 6 j 635–642 j May 10, 2016 637
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Figure 3. Accumulation of Spliced and
Unspliced Transcripts and Proteins from
Formerly Bivalent Genes in Dicer-Defi-
cient ESCs
(A) Gene-expression profiles of Dicer-defi-
cient ESCs were examined by miReduce for 30
UTR sequence motif enrichment.
(B) GSEA of bivalent genes compared with
miR-290 targets. FDR, false discovery rate;
NES, normalized enrichment score.
(C) GSEA results for eight sets of develop-
mentally regulated genes. Developmentally
regulated genes were separated into biva-
lent and non-bivalent. FDR, false discovery
rate; NES, normalized enrichment score.
(D) PCR strategy to distinguish primary (un-
spliced) from mature (spliced) transcripts.
(E) qRT-PCR analysis of primary transcripts
(blue bars) and mature transcripts (red bars)
in response to inducible ERt2Cre activation
in Dicerlox/lox ESCs by 4-OHT. Black bars
represent data for EtOH-treated control
cells. Mean ± SD of three independent ex-
periments. Expression is shown relative to
Ubc, Hprt, and Rn18s. *p < 0.05 (t test).
(F) The relationship between changes in gene
expression and EZH2 occupancy in Dicer-
deficient ESCs. Orange shading indicates loss
of EZH2 relative to increased global transcript
levels (p < 108; left). This association was
strongest for bivalent genes (p < 1011;
right). Gray shading indicates no significant
association.
(G) SILAC quantified 3,431 protein groups,
of which 169 (4.9%) were significantly
upregulated and 95 (2.8%) significantly
downregulated in Dicer-deficient ESCs (left).
Of 62 proteins encoded by bivalent genes,
14 (23%) were upregulated and 2 (3%)
downregulated (right). Proteins from biva-
lent genes were more likely to be deregu-
lated than proteins from non-bivalent genes
(odds ratio = 4.17). The odds for up- versus
downregulation were 0.56 for all proteins
and 0.14 for proteins from bivalent genes
(odds ratio = 3.93).
See also Figures S2 and S3.et al., 2015), but our microarray and proteomics data show
robust expression of Nup153 mRNA and NUP153 protein
in both control and Dicer-deficient ESCs, without any
indication of reduced expression in Dicer-deficient ESCs
(GSE60161). Finally, PRC2 occupancy may reflect, rather
than cause transcriptional repression (Riising et al., 2014).
Eviction of PRC2 by transcription could account for the
loss of EZH2 from some but not all of the formerly bivalent
promoters inDicer-deficientESCs, sincenotall formerlybiva-638 Stem Cell Reports j Vol. 6 j 635–642 j May 10, 2016lent genes showed increased expression of primary tran-
scripts (see below).
We profiled gene expression in control and Dicer-defi-
cient ESCs and identified sequence motif enrichment in
30 UTRs using miReduce. Highly enriched sequence motifs
corresponded to binding sites for the ESC miRNAs miR-
290–295 and miR-302, as well as miR-17-92 (Figure 3A).
The miR-290–295 cluster is the most highly expressed
miRNA population in ESCs (Zheng et al., 2011), and
miR-290-3p, miR-291a-3p, miR-291b-3p, miR-292-3p,
miR-294, and miR-295 contain the hexamer seed
AAGUGC, which is shared by the miR-302 cluster. The
miR-17-92 family contains the shifted seed AAAGUG and
likely shares targets with miR-290–295 and miR-302
(Leung et al., 2011; Ciaudo et al., 2009; Babiarz et al.,
2008). As expected, transcripts with 30 UTRmotifs for these
abundant miRNAs were significantly upregulated in Dicer-
deficient ESCs (Figure 3A). In addition,miReduce identified
30 UTR motifs that matched binding preferences of RNA
binding proteins (Figure S2A). We found the 30 UTRs of
bivalent genes enriched for miRNA motifs (p < 1015,
odds ratio = 2.91), including miR-290 (p = 1.17 3 106,
odds ratio = 2.00) andmiR-302 (p = 1.13 106, odds ratio =
1.95) (Figure S2A). Similar enrichment (p < 2.2 3 1016,
odds ratio = 2.22) was observed for an independently
defined set of bivalent genes (Mikkelsen et al., 2007) and
for the 2,110 bivalent genes that were bound by the
EZH2 in our ESCs (p < 2.2 3 1016, odds ratio = 3.18 for
any miRNA motif; p < 2.2 3 1016, odds ratio = 3.95 for
miR-290; and p < 1010, odds ratio = 4.32 for miR-302).
The genomic basis for the increased occurrence of miRNA
motifs was a greater than average 30 UTR length, rather
than a higher density of miRNA motifs in the 30 UTRs of
bivalent genes (Figure S2B).
Gene set enrichment analysis (GSEA) of developmentally
regulated genes showed that transcripts from bivalent
genes were preferentially upregulated in Dicer-deficient
ESCs, comparable with a set of Targetscan-predicted target
genes of miR-290–295 (Figure 3B). Eight sets of develop-
mental genes were used for comparison, and only two
showed false discovery rates below 25% (Figure 3C, top).
Each gene set contained a subset of bivalent genes, and
separating bivalent from non-bivalent developmentally
regulated genes showed significantly stronger upregulation
of the bivalent subset (Figure 3C, bottom). The deregulated
expression of bivalent genes was extensively validated by
qRT-PCR (Figure S2C). To determine whether the deregu-
lated expression of bivalent genes was due to the loss of
miRNAs or other aspects of Dicer-deficiency, we examined
gene expression in Dicer-deficient ESCs that had been re-
constituted with miR-290 (Sinkkonen et al., 2008). miR-
290 reconstitution significantly reduced the expression of
bivalent genes (Figure S3A). qRT-PCR of Dicer-deficient
ESCs reconstituted with miR-291a-3p in independent ex-
periments confirmed this result (Figure S3B).
We employed RT-PCR primers specific for intronic se-
quences to assess the abundance of unspliced (primary)
as well as spliced (mature) transcripts (see Figure 3D). In
these experiments we followed the kinetics of transcript
expression during the 4-OHT-induced deletion of Dicer in
ERt2Cre Dicerlox/lox ESCs (see Figure 1D). Some bivalent
genes showed selective upregulation of mature transcriptswith no (e.g.,Dock2) or little (e.g., Cacna1a) increase in pri-
mary transcript expression in Dicer-deficient ESCs (blue
bars in Figure 3E). Others, including Nr2f2, showed signif-
icant upregulation of primary transcripts (blue bars in
Figure 3E). Primary (blue bars in Figure 3E) and mature
transcripts (red bars in Figure 3E) were deregulated with
similar kinetics during the course of Dicer deletion (Fig-
ure 3E, data for EtOH-treated control cells are shown
in black). Therewas no clear temporal dissociation between
the deregulation of primary and mature transcripts. As
miRNAs are thought to act mainly on mature, cytoplasmic
transcripts in mammalian cells, the abundance of
primary—predominantly nuclear—transcripts can be an
indicator of transcriptional activity (Darnell, 2013). To
discover whether miRNAs were directly involved in the
regulation of primary transcripts, we transfected wild-
type ESCs with locked nucleic acid (LNA) inhibitors of
the miR-290–295 family. The LNA-mediated inhibition of
miR-290–295 in wild-type ESCs recapitulated the deregu-
lated expression of primary andmature bivalent gene tran-
scripts (Figure S3C).
To define the relationship between EZH2 redistribution
and gene expression, we integrated gene-expression and
ChIP-seq data. The loss of EZH2 from promoters correlated
with an increase in gene expression (p < 108). This corre-
lation was particularly strong for bivalent genes (p < 1011;
Figure 3F).
SILAC-based quantitative proteomics studies were per-
formed to address whether the increased expression of
transcripts translated into altered protein expression.
Control ESC extracts labeled with ‘‘heavy’’ amino acids
were added 1:1 to either control or Dicer-deficient ESC ex-
tracts. We reliably quantified 3,431 protein groups in
both control and Dicer-deficient ESCs (Figure 3G). Of
these, 169 (4.9%) were significantly upregulated and 95
(2.8%) were significantly downregulated in Dicer-defi-
cient ESCs (Figure 3G, left). Of 62 proteins encoded by
bivalent genes 14 (23%) were upregulated, a much greater
fraction than the 4.9% observed genome-wide (Figure 3G,
right). Proteins encoded by two bivalent genes (3%) were
downregulated in Dicer-deficient ESCs (Figure 3G, right).
Hence, proteins encoded by bivalent genes were preferen-
tially upregulated in Dicer-deficient ESCs (odds ratio =
3.93).
To explore whether the impact of DICER on bivalency
extends to serum + LIF culture conditions, we analyzed
ChIP-seq data for the PRC2 core component SUZ12 (Kanel-
lopoulou et al., 2015). Similarly to Dicer deletion under
semi-2i conditions, 968 (46.7%) of 2,074 bivalent genes
showed reduced SUZ12 binding in Dicer-deficient ESCs in
serum + LIF (Figure 4A). Hence, DICER is required for the
maintenance of bivalency in ESCs in serum + LIF as well
as in semi-2i conditions.Stem Cell Reports j Vol. 6 j 635–642 j May 10, 2016 639
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Figure 4. miRNAs Rescue PRC2 Binding to
Formerly Bivalent Promoters in Dicer-
Deficient ESCs
(A) SUZ12 occupancy at transcriptional start
sites of bivalent genes in control (black) and
Dicer-deficient ESCs (red) in serum + LIF. 968
of 2,074 bivalent genes (46.7%) and 366 of
15,850 non-bivalent genes (2.3%) showed
reduced SUZ12 binding in Dicer-deficient
ESCs (p < 10300).
(B) Control or Dicer-deficient ESCs were
transfected with miR-294, a member of the
ESC miRNA family miR-290–295. ChIP for the
PRC2 core component EZH2 was done 2 days
later and analyzed by real-time PCR (mean ±
SE of two independent experiments).To address whether the bivalent state requires miRNAs or
other Dicer-dependent functions, we reconstituted Dicer-
deficient ESCs with miR-294, a member of the miR-290–
295 miRNA family. ChIP-PCR showed that EZH2 binding
was restored 48 hr later at the Gata3, Pax6, and Nr2f2 pro-
moters (Figure 4B). Thus, reconstitution of Dicer-deficient
ESCs with amember of the 290–295miRNA family was suf-
ficient to rescue PRC2 occupancy of at least a subset of loci
that lost the bivalent state in Dicer-deficient ESCs.
The expression of bivalent genes is regulated at multi-
ple levels (Brookes et al., 2012; Margueron and Reinberg,
2011; Simon and Kingston, 2013; Jia et al., 2012). We
have shown that transcripts from bivalent genes are pref-
erentially targeted by miRNAs because their 30 UTRs
contain significantly more miRNA binding sites. The plu-
ripotency-associated transcription factors OCT4, SOX2,
and NANOG control miRNA expression in ESCs (Marson
et al., 2008), linking the regulation of bivalent genes
by ESC miRNAs to the ESC core regulatory network (Fig-
ure S4). An unexpected finding of our study is that
miRNAs are required for the recruitment of PRC2 compo-
nents to bivalent genes, and thereby the state of biva-
lency itself.EXPERIMENTAL PROCEDURES
Dicerlox/lox ERT2Cremouse ESCs (Nesterova et al., 2008) were adapt-
ed to feeder-free conditions on gelatin-coated plates (0.1%) in 50%
knockout DMEM, 10% fetal calf serum, and 50% neurobasal
DMEM/F12, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml
streptomycin, 100 mM b-mercaptoethanol, 0.5 mM non-essential
amino acids, 0.5% N2 supplement, 1% (v/v) B27 supplement,
1 mM PD032590, and 3 mM CHIR99021 (Stemgent) as described by640 Stem Cell Reports j Vol. 6 j 635–642 j May 10, 2016Ying et al. (2008). For the conditional deletion of Dicer, Dicerlox/lox
ERt2CreESCswere treatedwith80nM4-OHT.ToblockmiRNA func-
tion, we transfected ESCs with LNA inhibitors (500 nM; Exiqon)
ornegative control oligo (#199004-00, 500nM)usingLipofectamine
2000 and assayed them 24 hr later. To mimic mRNA function,
we transfected ESCs with miR-291a-3p mimic (C-310470-05,
100 nM) or control (CN-001000-01, 100 nM) oligos (Dharmacon)
using DharmFECT Reagent #1 and assayed them 24 hr later. For
rescue experiments, ESCs were transfected with miR-294-3p mimic
(C-310474-03-0002, 100 nM, Dharmacon) using Lipofectamine
2000 and assayed 48 hr later. Details of materials and methods for
gene expression, western blotting, and proteomics are given in
Supplemental Experimental Procedures.ACCESSION NUMBERS
The accession number for the microarray and EZH2 ChIP-seq data
reported in this paper is GEO: GSE60161, and the proteomics
data are at ProteomeXchange (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?token=adqpgoaqpnehpwj&acc=GSE60161).SUPPLEMENTAL INFORMATION
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